Center for Medical Genetics Ghent University Hospital Ghent Belgium

Center of Oncocytogenomics Institute of Medical Biochemistry and Laboratory Diagnostics General University Hospital and 1st Faculty of Medicine of Charles University Prague Czech Republic; and

Dana Farber and Boston Children's Cancer and Blood Disorders Center Boston MA

Department of Biodiagnostic Sciences and Technologies The Institute of Nuclear and Radiological Sciences and Technology Energy and Safety National Centre for Research 'Demokritos' Athens Greece

Department of Clinical Genetics Erasmus MC University Medical Center Rotterdam Rotterdam The Netherlands

Department of Clinical Genetics Faculty of Medicine Collegium Medicum in Bydgoszcz Nicolaus Copernicus University Toruń Poland

Department of Computational Biology St Jude Children's Research Hospital Memphis TN

Department of Genetics The National Institute of Oncology Bratislava Slovakia

Department of Haematology Addenbrooke's Hospital Cambridge United Kingdom

Department of Hematology Genetics Unit Centro de Investigación Biomédica en Red de Oncología Hospital Universitario y Politécnico La Fe Valencia Spain

Department of Hematology Hokkaido University Faculty of Medicine Graduate School of Medicine Sapporo Japan

Department of Hematology St Jude Children's Research Hospital Memphis TN

Department of Human Genetics Hannover Medical School Hannover Germany

Department of Laboratory Medicine Clinical Center National Institutes of Health Bethesda MD

Department of Leukemia University of Texas MD Anderson Cancer Center Houston TX

Department of Medicine Division of Hematology University of Washington Seattle WA

Department of Medicine Hematology and Bone Marrow Transplantation Unit University of Perugia Perugia Italy

Department of Oncology and

Department of Pathology Boston Children's Hospital Boston MA

Department of Pediatric Hematology and Oncology Charles University and University Hospital Motol Prague Czech Republic

Department of Pediatric Hematology and Oncology Oslo University Hospital Oslo Norway

Department of Pediatrics Aarhus University Hospital Skejby Aarhus Denmark

Department of Pediatrics and

Department of Pediatrics Hematology Oncology Baylor College of Medicine Houston TX

Department of Pediatrics Section of Pediatric Oncology Hematology Immunology and Nephrology Skåne University Hospital Lund Sweden

Department of Women's and Children's Health Karolinska Institutet and Karolinska University Hospital Stockholm Sweden

Division of Pediatric Hematology and Oncology Department of Pediatrics and Adolescent Medicine Medical Center Faculty of Medicine and

Dutch Childhood Oncology Group Utrecht The Netherlands

Faculty of Biology University of Freiburg Freiburg Germany

German Cancer Consortium Heidelberg Germany

Hematology Department Oncology Institute Francisco Gentil Lisbon Portugal

Immune Deficiency Cellular Therapy Program Center for Cancer Research National Cancer Institute Bethesda MD

Labdia Labordiagnostik GmbH Clinical Genetics Vienna Austria

Laboratory for Oncology University Children's Hospital Zürich Zürich Switzerland

Laboratory of Clinical Immunology and Microbiology National Institute of Allergy and Infectious Diseases National Institutes of Health Bethesda MD

Laboratory of Molecular Diagnostics Central Hospital of Southern Pest Budapest Hungary

Medical Genetics Department of Medicine and Surgery University of Insubria Varese Italy

National Children's Cancer Service Children's Health Ireland at Crumlin Dublin Ireland

New Children's Hospital Pediatric Research Centre University of Helsinki and Helsinki University Hospital Helsinki Finland

Pediatric Hematology and Oncology Schneider Children's Medical Center of Israel Petah Tikva Israel

Sackler Faculty of Medicine Tel Aviv University Israel

St Anna Childreńs Hospital and Cancer Research Institute Pediatric Clinic Medical University of Vienna Vienna Austria

See more in PubMed

Hsu AP, Sampaio EP, Khan J, et al. . Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood. 2011;118(10):2653-2655. PubMed PMC

Dickinson RE, Griffin H, Bigley V, et al. . Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. Blood. 2011;118(10):2656-2658. PubMed PMC

Hahn CN, Chong CE, Carmichael CL, et al. . Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet. 2011;43(10):1012-1017. PubMed PMC

Pasquet M, Bellanné-Chantelot C, Tavitian S, et al. . High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia. Blood. 2013;121(5):822-829. PubMed PMC

Nováková M, Žaliová M, Suková M, et al. . Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome. Haematologica. 2016;101(6): 707-716. PubMed PMC

Wlodarski MW, Hirabayashi S, Pastor V, et al. ; EWOG-MDS . Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents. Blood. 2016;127(11):1387-1397, quiz 1518. PubMed

Wang L, Ogawa S, Hangaishi A, et al. . Molecular characterization of the recurrent unbalanced translocation der(1;7)(q10;p10). Blood. 2003;102(7):2597-2604. PubMed

Hussain FT, Nguyen EP, Raza S, et al. . Sole abnormalities of chromosome 7 in myeloid malignancies: spectrum, histopathologic correlates, and prognostic implications. Am J Hematol. 2012;87(7):684-686. PubMed

Ganster C, Müller-Thomas C, Haferlach C, et al. . Comprehensive analysis of isolated der(1;7)(q10;p10) in a large international homogenous cohort of patients with myelodysplastic syndromes. Genes Chromosomes Cancer. 2019;58(10):689-697. PubMed

Göhring G, Michalova K, Beverloo HB, et al. . Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome. Blood. 2010;116(19):3766-3769. PubMed

Ganapathi KA, Townsley DM, Hsu AP, et al. . GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia. Blood. 2015;125(1):56-70. PubMed PMC

Wang X, Muramatsu H, Okuno Y, et al. . GATA2 and secondary mutations in familial myelodysplastic syndromes and pediatric myeloid malignancies. Haematologica. 2015;100(10):e398-e401. PubMed PMC

Schwartz JR, Ma J, Lamprecht T, et al. . The genomic landscape of pediatric myelodysplastic syndromes. Nat Commun. 2017;8(1):1557. PubMed PMC

Kurata T, Shigemura T, Muramatsu H, Okuno Y, Nakazawa Y. A case of GATA2-related myelodysplastic syndrome with unbalanced translocation der(1;7)(q10;p10). Pediatr Blood Cancer. 2017;64(8): e26419. PubMed

Donadieu J, Lamant M, Fieschi C, et al. ; French GATA2 study group . Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients. Haematologica. 2018;103(8):1278-1287. PubMed PMC

Pozdnyakova O, Miron PM, Tang G, et al. . Cytogenetic abnormalities in a series of 1,029 patients with primary myelodysplastic syndromes: a report from the US with a focus on some undefined single chromosomal abnormalities. Cancer. 2008;113(12):3331-3340. PubMed

Zhang T, Xu Y, Pan J, et al. . High frequency of RUNX1 mutation in myelodysplastic syndrome patients with whole-arm translocation of der(1;7)(q10;p10). Leukemia. 2017;31(10):2257-2260. PubMed

Wlodarski MW, Collin M, Horwitz MS. GATA2 deficiency and related myeloid neoplasms. Semin Hematol. 2017;54(2):81-86. PubMed PMC

Wehr C, Grotius K, Casadei S, et al. . A novel disease-causing synonymous exonic mutation in GATA2 affecting RNA splicing. Blood. 2018;132(11):1211-1215. PubMed PMC

Kozyra EJ, Pastor VB, Lefkopoulos S, et al. ; European Working Group of MDS in Childhood (EWOG-MDS) . Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency. Leukemia. 2020;34(10):2673-2687. PubMed PMC

Fox LC, Tan M, Brown AL, et al. . A synonymous GATA2 variant underlying familial myeloid malignancy with striking intrafamilial phenotypic variability. Br J Haematol. 2020;190(5):e297-e301. PubMed

Gao J, Gentzler RD, Timms AE, et al. . Heritable GATA2 mutations associated with familial AML-MDS: a case report and review of literature [published correction appears in J Hematol Oncol. 2015;8:131]. J Hematol Oncol. 2014;7(1):36. PubMed PMC

Hahn CN, Brautigan PJ, Chong CE, et al. . Characterisation of a compound in-cis GATA2 germline mutation in a pedigree presenting with myelodysplastic syndrome/acute myeloid leukemia with concurrent thrombocytopenia. Leukemia. 2015;29(8):1795-1797. PubMed

Catto LFB, Borges G, Pinto AL, et al. . Somatic genetic rescue in hematopoietic cells in GATA2 deficiency. Blood. 2020;136(8):1002-1005. PubMed

Pastor V, Hirabayashi S, Karow A, et al. . Mutational landscape in children with myelodysplastic syndromes is distinct from adults: specific somatic drivers and novel germline variants. Leukemia. 2017;31(3):759-762. PubMed

Pastor VB, Sahoo SS, Boklan J, et al. . Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7. Haematologica. 2018;103(3):427-437. PubMed PMC

Fernandez AGL, Crescenzi B, Pierini V, et al. . A distinct epigenetic program underlies the 1;7 translocation in myelodysplastic syndromes. Leukemia. 2019;33(10):2481-2494. PubMed PMC

Age-dependent phenotypic and molecular evolution of pediatric MDS arising from GATA2 deficiency

Spontaneous remission and loss of monosomy 7: a window of opportunity for young children with SAMD9L syndrome